Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
AOD 9604 is available through peptide research suppliers
initial results have been reported at an earlier Pernicious Anaemia Society meeting, and these presentations can be found online on the PAS website and / or YouTube
Its overactivation disrupts nicotinamide metabolism, reduces NAD+ levels, promotes hepatic lipid accumulation and lipotoxicity, and represents an important therapeutic target for hepatic metabolic disorders
According to doctors, the combination of antidepressants and vitamin B12 leads to an improvement in the condition of patients with depression compared to taking medication alone
Diabetes 64 (8), 28472858
Established Safety Profile Across all clinical studies, AOD-9604 demonstrated excellent safety and tolerability
